MANKIND PHARMA: SALES GROWTH AND PRODUCT MIX
Popular topics to explore
Hemraj Singh Sikarwar
Latest posts, stock views and market insights from Hemraj Singh Sikarwar on StockGro.
SEBI-Registered Research Analyst · INH000016719 · View advisor profile
BANK OF MAHARASHTRA: PROFITABILITY AND ASSET QUALITY I
DALMIA BHARAT: CEMENT DEMAND AND EBITDA PER TONNE
JK CEMENT: VOLUME GROWTH VERSUS COST PRESSURE
Jindal Stainless: profit rises 11%, demand remains strong
Jindal Stainless Ltd reported an 11.1% year-on-year increase in net profit to ₹898 crore in Q2 FY27. Revenue rose 18.2% to ₹12,874 crore, reflecting healthy business activity during the quarter. The important takeaway is that revenue grow…
BAJAJ AUTO: WHAT TO WATCH AHEAD OF RESULTS
Bharat Electronics: ₹1,011 crore in fresh orders
Bharat Electronics Ltd has secured additional orders worth ₹1,011 crore since its previous order disclosure on October 13, 2026. The new orders cover radar systems, communication equipment, sonar, jammers, upgrades, spares and related serv…
HINDUNILVR : Is the Next Growth Driver Volume or Pricing?
Bajaj Finance: profit grows 29%, asset quality improves
Bajaj Finance Ltd reported a 28.7% year-on-year increase in consolidated net profit to ₹6,367 crore in Q2 FY27. Net interest income rose 23.6% to ₹13,335 crore, while pre-provisioning operating profit increased 23.2% to ₹10,699 crore. The…
ONGC: Do Higher Oil Prices Always Mean Higher Profits
Oil prices remain an important driver of sentiment in energy stocks. But for Oil and Natural Gas Corporation, the relationship between crude prices and profitability is not always straightforward.
PNB: profit growth and cleaner books put stock in focus
Punjab National Bank reported a 12.8% YoY increase in Q2 FY27 net profit to ₹5,532 crore. Net interest income also grew 10.8% YoY to ₹11,601 crore, while net NPA improved to 0.25% from 0.28% in the previous quarter. The combination of ear…
Yes Bank: profit jumps 65%, but the test is growth quality
Yes Bank Ltd reported a 65.1% YoY increase in Q2 FY27 net profit to ₹1,080 crore. Net interest income also grew 22.7% YoY to ₹2,822 crore, giving the quarter a strong start. The headline numbers are encouraging, but for a bank that has be…
Max : Can Capacity Expansion Improve Future Earnings?
Adani : How Should Investors Evaluate a Business Incubator?
Cipla: A Defensive Business Does Not Mean Risk-Free Returns
Pharmaceutical companies can benefit from recurring demand for medicines, but their earnings remain exposed to regulatory decisions, competition and product pricing.
For
Adani Ports: Cargo Volumes Tell Only Part of the Story
Sun Pharma: Beyond the Defensive Pharma Label
L&T: Why Order Wins Must Translate Into Profits
IndiGo Falls 1.91%: What Could Influence the Next Move?
JSW Steel: Rising Demand Does Not Always Mean Rising Profits



















